All Cases

Emerging Markets Healthcare Systems and Service Providers

Evaluated the global strategic launch plan and tailored it to fit the needs of the local marketplace, maximizing the patient pool touched by commercialization efforts

Assessed challenges to improve the quality of multiple sclerosis care in LATAM for a large pharmaceutical company looking to publish a position paper to guide the improvement of care for these patients

Estimated NSCLC burden in Mexico based on RWE to inform clinical management and drive market share of more effective therapies

Assessed the burden of inherited retina diseases to provide several emerging markets with policy-informing data and financial models to raise awareness of the burden of these diseases

Mapped treatment landscape for a rare ophthalmology indication in APAC for a mid-sized pharmaceutical company, including eligible patient population and pricing levels

Evaluated emerging markets for a large pharma client to understand specific health system support strategies required to successfully manage a new multiple sclerosis treatment

Assessed the Mexican private payer migraine market to understand the current market situation, synthesize the commercial opportunity and develop a launch strategy for migraine products

Defined and compared the treatment paradigms for two types of depression in several LATAM markets with the global “gold standard” to understand the value of programs designed to improve patient care